ACER logo

Acer Therapeutics (ACER) Accounts Payable

Annual Accounts Payable

$3.81 M
+$2.41 M+171.27%

December 31, 2022

Summary

Performance

1-Year Change

+171.27%

3-Year Change

+579.61%

5-Year Change

+3876.33%

15-Year Change

+3876.33%

ACER Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$3.81 M
ACER annual accounts payable is currently at an all-time high

3-Year Low

$1.41 M
ACER annual accounts payable is currently +171.27% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
ACER previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
ACER next annual earnings announcement has not yet been scheduled

OtherACERbalance sheetmetrics:

Annual Accounts Receivable

$0.00
ACER annual accounts receivable is $0.00

Annual Total Liabilities

$28.39 M
ACER annual total liabilities is $28.39 million

Annual Total Assets

$11.62 M
ACER annual total assets is $11.62 million

Annual Current Assets

$3.52 M
ACER annual total current assets is $3.52 million

Quarterly Accounts Payable

$5.71 M
+$4.11 M+256.59%

June 30, 2023

Summary

Performance

3-Month Change

+256.59%

1-Year Change

+63.62%

3-Year Change

+1215.01%

5-Year Change

+563.54%

ACER Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$5.71 M
ACER quarterly accounts payable is currently at an all-time high

3-Year Low

$1.41 M
ACER quarterly accounts payable is currently +306.47% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
ACER previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
ACER next earnings announcement has not yet been scheduled

OtherACERbalance sheetmetrics:

Quarterly Accounts Receivable

-
ACER quarterly accounts receivable value is unknown

Quarterly Total Liabilities

$47.89 M
ACER quarterly total liabilities is $47.89 million

Quarterly Total Assets

$14.65 M
ACER quarterly total assets is $14.65 million

Quarterly Current Assets

$6.75 M
ACER quarterly total current assets is $6.75 million

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

ACER Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+171.3%+63.6%
3 y3 years+579.6%+1215.0%
5 y5 years+3876.3%+563.5%

ACER Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-63.1%at high-75.4%
5 y5-yearat high-85.3%at high-94.0%
alltimeall timeat high-97.5%at high-99.9%

Acer Therapeutics Accounts Payable History

DateAnnualQuarterly
Jun 2023
-
$5.71 M(+256.6%)
Mar 2023
-
$1.60 M(-58.0%)
Dec 2022
$3.81 M(+171.3%)
$3.81 M(-18.6%)
Sep 2022
-
$4.69 M(+34.2%)
Jun 2022
-
$3.49 M(+72.9%)
Mar 2022
-
$2.02 M(+43.7%)
Dec 2021
$1.41 M(-15.9%)
$1.41 M(+29.1%)
Sep 2021
-
$1.09 M(-39.8%)
Jun 2021
-
$1.81 M(+321.7%)
Mar 2021
-
$428.90 K(-74.3%)
Dec 2020
$1.67 M(+198.0%)
$1.67 M(+82.9%)
Sep 2020
-
$914.20 K(+110.4%)
Jun 2020
-
$434.50 K(+26.0%)
Mar 2020
-
$344.80 K(-38.5%)
Dec 2019
$561.10 K(-45.7%)
$561.10 K(+1795.6%)
Sep 2019
-
$29.60 K(-98.1%)
Jun 2019
-
$1.54 M(+2414.4%)
Mar 2019
-
$61.20 K(-94.1%)
Dec 2018
$1.03 M(+978.0%)
$1.03 M(+73.6%)
Sep 2018
-
$595.40 K(-30.9%)
Jun 2018
-
$861.10 K(+164.5%)
Mar 2018
-
$325.50 K(+239.4%)
Dec 2017
$95.90 K(-74.6%)
$95.90 K(-82.2%)
Sep 2017
-
$539.40 K(+7717.4%)
Jun 2017
-
$6900.00(-97.7%)
Mar 2017
-
$298.00 K(-21.2%)
Dec 2016
$378.00 K(-48.9%)
$378.00 K(-63.0%)
Sep 2016
-
$1.02 M(+76.8%)
Jun 2016
-
$577.80 K(+2.8%)
Mar 2016
-
$562.20 K(-24.0%)
Dec 2015
$739.90 K(+5.3%)
$739.90 K(-27.3%)
Sep 2015
-
$1.02 M(-11.4%)
Jun 2015
-
$1.15 M(-0.3%)
Mar 2015
-
$1.15 M(+64.1%)
Dec 2014
$702.50 K(+0.9%)
$702.50 K(+88.8%)
Sep 2014
-
$372.00 K(-55.5%)
Jun 2014
-
$835.60 K(+16.8%)
Mar 2014
-
$715.30 K(+2.7%)
Dec 2013
$696.20 K(+68.9%)
$696.20 K(-23.9%)
Sep 2013
-
$914.30 K(-20.9%)
Jun 2013
-
$1.16 M(+39.2%)
Mar 2013
-
$830.70 K(+101.6%)
Dec 2012
$412.10 K(-16.1%)
$412.10 K(-22.9%)
Sep 2012
-
$534.40 K(-3.9%)
Jun 2012
-
$556.10 K(-66.9%)
Mar 2012
-
$1.68 M(+242.3%)
Dec 2011
$491.30 K
$491.30 K(+14.4%)
DateAnnualQuarterly
Sep 2011
-
$429.60 K(-13.4%)
Jun 2011
-
$495.80 K(-25.8%)
Mar 2011
-
$667.90 K(+78.7%)
Dec 2010
$373.80 K(-40.2%)
$373.80 K(-23.0%)
Sep 2010
-
$485.30 K(-4.4%)
Jun 2010
-
$507.40 K(+0.6%)
Mar 2010
-
$504.30 K(-19.4%)
Dec 2009
$625.60 K(-2.9%)
$625.60 K(+3.1%)
Sep 2009
-
$607.00 K(+6.4%)
Jun 2009
-
$570.70 K(-10.0%)
Mar 2009
-
$634.10 K(-1.6%)
Dec 2008
$644.60 K(-35.1%)
$644.60 K(-32.5%)
Sep 2008
-
$954.30 K(+13.4%)
Jun 2008
-
$841.50 K(-3.6%)
Mar 2008
-
$872.80 K(-12.1%)
Dec 2007
$992.50 K(+14.2%)
$992.50 K(-19.1%)
Sep 2007
-
$1.23 M(-3.7%)
Jun 2007
-
$1.27 M(+15.2%)
Mar 2007
-
$1.11 M(+27.2%)
Dec 2006
$868.90 K(+26.0%)
$868.90 K(-18.8%)
Sep 2006
-
$1.07 M(+56.8%)
Jun 2006
-
$682.80 K(-11.7%)
Mar 2006
-
$773.30 K(+12.2%)
Dec 2005
$689.50 K(-42.0%)
$689.50 K(+32.3%)
Sep 2005
-
$521.20 K(-17.3%)
Jun 2005
-
$630.30 K(-0.6%)
Mar 2005
-
$633.80 K(-46.7%)
Dec 2004
$1.19 M(+412.1%)
$1.19 M(+517.8%)
Sep 2004
-
$192.40 K(+18.9%)
Jun 2004
-
$161.80 K(+134.2%)
Mar 2004
-
$69.10 K(+0.9%)
Dec 2003
-
$68.50 K(-70.5%)
Sep 2003
$232.10 K(-34.7%)
$232.10 K(-36.7%)
Jun 2003
-
$366.60 K(0.0%)
Mar 2003
-
$366.60 K(+1.8%)
Dec 2002
-
$360.00 K(+1.3%)
Sep 2002
$355.50 K(-10.5%)
$355.50 K(-11.0%)
Jun 2002
-
$399.60 K(+0.2%)
Mar 2002
-
$398.90 K(+0.5%)
Sep 2001
$397.10 K(+18.3%)
$397.10 K(+11.4%)
Jun 2001
-
$356.50 K(-6.1%)
Mar 2001
-
$379.80 K(-3.0%)
Dec 2000
-
$391.50 K(+16.7%)
Sep 2000
$335.60 K(+53.2%)
$335.60 K(-23.4%)
Jun 2000
-
$438.10 K(+55.9%)
Mar 2000
-
$281.00 K(-16.5%)
Dec 1999
-
$336.50 K(+53.6%)
Sep 1999
$219.10 K
$219.10 K

FAQ

  • What is Acer Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Acer Therapeutics?
  • What is Acer Therapeutics annual accounts payable year-on-year change?
  • What is Acer Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Acer Therapeutics?
  • What is Acer Therapeutics quarterly accounts payable year-on-year change?

What is Acer Therapeutics annual accounts payable?

The current annual accounts payable of ACER is $3.81 M

What is the all time high annual accounts payable for Acer Therapeutics?

Acer Therapeutics all-time high annual accounts payable is $3.81 M

What is Acer Therapeutics annual accounts payable year-on-year change?

Over the past year, ACER annual accounts payable has changed by +$2.41 M (+171.27%)

What is Acer Therapeutics quarterly accounts payable?

The current quarterly accounts payable of ACER is $5.71 M

What is the all time high quarterly accounts payable for Acer Therapeutics?

Acer Therapeutics all-time high quarterly accounts payable is $5.71 M

What is Acer Therapeutics quarterly accounts payable year-on-year change?

Over the past year, ACER quarterly accounts payable has changed by +$2.22 M (+63.62%)